Table 2.
Details of transjugular intrahepatic portosystemic shunt patients.
| Age | Sex | Aetiology of cirrhosis | TIPS indication |
|---|---|---|---|
| 48 | F | NASH | Ascites |
| 50 | M | Alcohol | Ascites |
| 64 | F | Primary sclerosing cholangitis | Variceal bleed |
| 76 | M | Alcohol/haemochromatosis | Ascites |
| 50 | F | Alcohol | Ascites |
| 59 | F | Alcohol | Ascites |
| 58 | M | HBV and HDV co-infection | Ascites |
| 60 | M | Primary biliary cholangitis | Hepatic hydrothorax |
| 54 | M | Cryptogenic | Ascites |
| 69 | F | Autoimmune hepatitis | Ascites |
| 61 | F | NASH | Variceal bleed |
| 50 | M | Alcohol | Variceal bleed |
| 53 | M | Alcohol | Ascites |
| 60 | F | Autoimmune hepatitis | Ascites |
| 62 | M | HCV | Ascites |
| 61 | F | Alcohol | Ascites |
| 74 | M | Alcohol | Ascites |
NASH, non-alcoholic steatohepatitis; TIPS, transjugular intrahepatic portosystemic shunt.